HIM
AXNX

Hillsdale Investment Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Hillsdale Investment Management’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-70
Closed -$4.36K – 694
2023
Q4 		$4.36K Hold
70
– – ﹤0.01% 549
2023
Q3 		$3.93K Buy
70
+20
+40% +$1.13K ﹤0.01% 548
2023
Q2 		$2.52K Sell
50
-11,550
-100% -$615K ﹤0.01% 539
2023
Q1 		$633K Hold
11,600
– – 0.05% 262
2022
Q4 		$725K Buy
11,600
+1,000
+9% +$66.4K 0.06% 224
2022
Q3 		$747K Buy
+10,600
New +$731K 0.07% 215

Other funds holding AXNX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

Hillsdale Investment Management's AXNX Position: Q1 2024 in Review

Hillsdale Investment Management sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2024, closing a stake of 70 shares — an estimated $4.36K sold.

Hillsdale Investment Management first reported a position in AXNX in Q3 2022 and held it in 6 quarters. The position peaked at $747K in Q3 2022. 235 funds tracked by Wall St. Rank hold AXNX as of Q1 2024.

  • Hillsdale Investment Management reported no remaining Axonics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Hillsdale Investment Management sold 70 Axonics, Inc. Common Stock shares in Q1 2024, an estimated $4.36K.
  • Hillsdale Investment Management first reported a position in Axonics, Inc. Common Stock in Q3 2022 and held it in 6 quarters.
  • Hillsdale Investment Management's Axonics, Inc. Common Stock position peaked at $747K in Q3 2022.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2024.

Based on Hillsdale Investment Management's 13F filing for Q1 2024, filed 10 May 2024.